679 related articles for article (PubMed ID: 11994346)
1. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
Lazar L; Kauli R; Pertzelan A; Phillip M
J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
[TBL] [Abstract][Full Text] [Related]
2. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
[TBL] [Abstract][Full Text] [Related]
3. Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity.
Lazar L; Padoa A; Phillip M
J Clin Endocrinol Metab; 2007 Sep; 92(9):3483-9. PubMed ID: 17579199
[TBL] [Abstract][Full Text] [Related]
4. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
5. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
6. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
7. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method.
Kauli R; Galatzer A; Kornreich L; Lazar L; Pertzelan A; Laron Z
Horm Res; 1997; 47(2):54-61. PubMed ID: 9030968
[TBL] [Abstract][Full Text] [Related]
8. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
Lanes R; Soros A; Jakubowicz S
J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
[TBL] [Abstract][Full Text] [Related]
10. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
11. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
Poomthavorn P; Suphasit R; Mahachoklertwattana P
Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
[TBL] [Abstract][Full Text] [Related]
12. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
14. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
16. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
Liang Y; Wei H; Li J; Hou L; Zhang J; Wu W; Ying Y; Luo X
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):839-46. PubMed ID: 25719299
[TBL] [Abstract][Full Text] [Related]
17. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
Saggese G; Federico G; Barsanti S; Fiore L
J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
[TBL] [Abstract][Full Text] [Related]
18. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
Weise M; Flor A; Barnes KM; Cutler GB; Baron J
J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
[TBL] [Abstract][Full Text] [Related]
19. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
[TBL] [Abstract][Full Text] [Related]
20. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
